Assembly Biosciences Valuation
| ASMB Stock | USD 16.30 1.10 7.24% |
At this time, the firm appears to be overvalued. Assembly Biosciences shows a prevailing Real Value of $8.25 per share. The current price of the firm is $16.3. Our model approximates the value of Assembly Biosciences from analyzing the firm fundamentals such as Profit Margin of (2.12) %, current valuation of 3.1 M, and Return On Equity of -1.02 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Assembly Biosciences' valuation include:
Price Book 3.7156 | Enterprise Value 3.1 M | Enterprise Value Ebitda 0.4244 | Price Sales 4.4977 | Enterprise Value Revenue 0.1096 |
Overvalued
Today
Please note that Assembly Biosciences' price fluctuation is relatively risky at this time. Calculation of the real value of Assembly Biosciences is based on 3 months time horizon. Increasing Assembly Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Assembly Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Assembly Stock. However, Assembly Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.3 | Real 8.25 | Target 3.0 | Hype 15.19 | Naive 15.88 |
The real value of Assembly Stock, also known as its intrinsic value, is the underlying worth of Assembly Biosciences Company, which is reflected in its stock price. It is based on Assembly Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Assembly Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Assembly Biosciences helps investors to forecast how Assembly stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Assembly Biosciences more accurately as focusing exclusively on Assembly Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Assembly Biosciences' intrinsic value based on its ongoing forecasts of Assembly Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Assembly Biosciences' closest peers. If more than one evaluation category is relevant for Assembly Biosciences we suggest using both methods to arrive at a better estimate.
Assembly Biosciences Cash |
|
Assembly Valuation Trend
Comparing Assembly Biosciences' enterprise value against its market capitalization is a good way to estimate the value of Assembly Biosciences uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Assembly Biosciences Total Value Analysis
Assembly Biosciences is presently expected to have valuation of 3.1 M with market capitalization of 96.62 M, debt of 2.34 M, and cash on hands of 116.69 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Assembly Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.1 M | 96.62 M | 2.34 M | 116.69 M |
Assembly Biosciences Investor Information
About 32.0% of the company shares are held by company insiders. The book value of Assembly Biosciences was presently reported as 7.5. The company recorded a loss per share of 6.89. Assembly Biosciences had not issued any dividends in recent years. The entity had 1:12 split on the 12th of February 2024. Based on the key indicators related to Assembly Biosciences' liquidity, profitability, solvency, and operating efficiency, Assembly Biosciences is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Assembly Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Assembly Biosciences has an asset utilization ratio of 5.24 percent. This suggests that the Company is making $0.0524 for each dollar of assets. An increasing asset utilization means that Assembly Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Assembly Biosciences Ownership Allocation
The market capitalization of Assembly Biosciences is $96.62 Million. Assembly Biosciences retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. On February 10, 2021, Representative Chris Jacobs of US Congress acquired under $15k worth of Assembly Biosciences's common stock.Assembly Biosciences Profitability Analysis
The company reported the previous year's revenue of 7.16 M. Net Loss for the year was (61.23 M) with loss before overhead, payroll, taxes, and interest of (63.9 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Assembly Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Assembly Biosciences and how it compares across the competition.
About Assembly Biosciences Valuation
The stock valuation mechanism determines Assembly Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Assembly Biosciences. We calculate exposure to Assembly Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Assembly Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -41.7 M | -39.7 M | |
| Pretax Profit Margin | (9.82) | (10.32) | |
| Operating Profit Margin | (10.38) | (10.90) | |
| Net Loss | (9.83) | (10.32) | |
| Gross Profit Margin | (5.24) | (4.98) |
Assembly Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 4.6 M |
Assembly Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Assembly Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Assembly we look at many different elements of the entity such as Assembly's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Assembly Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Assembly Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Assembly Biosciences' worth.Complementary Tools for Assembly Stock analysis
When running Assembly Biosciences' price analysis, check to measure Assembly Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assembly Biosciences is operating at the current time. Most of Assembly Biosciences' value examination focuses on studying past and present price action to predict the probability of Assembly Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assembly Biosciences' price. Additionally, you may evaluate how the addition of Assembly Biosciences to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |